THE COMBINATION OF DUVELISIB AND ROMIDEPSIN (DR) IS HIGHLY ACTIVE AGAINST RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA WITH LOW RATES OF TRANSAMINITIS: FINAL RESULTS. (17th June 2021)

Record Type:: Journal Article
Title:: THE COMBINATION OF DUVELISIB AND ROMIDEPSIN (DR) IS HIGHLY ACTIVE AGAINST RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA WITH LOW RATES OF TRANSAMINITIS: FINAL RESULTS. (17th June 2021)
Main Title:: THE COMBINATION OF DUVELISIB AND ROMIDEPSIN (DR) IS HIGHLY ACTIVE AGAINST RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA WITH LOW RATES OF TRANSAMINITIS: FINAL RESULTS
Authors:: Horwitz, S. M.
Moskowitz, A. J.
Mehta‐Shah, N.
Jacobsen, E. D.
Khodadoust, M. S.
Ganesan, N.
Drill, E.
Hancock, H.
Davey, T.
Myskowski, P.
Maccaro, C.
Blouin, W.
Schwieterman, J.
Cathcart, E.
Fang, S.
Perez, L.
Ryu, S.
Galasso, N.
Straus, D.
Fisher, D. C.
Kumar, A.
Noy, A.
Falchi, L.
Dogan, A.
Kim, Y. H.
Weinstock, D.
Abstract:
Is Part Of:: Hematological oncology. Volume 39(2021)Supplement 2
Journal:: Hematological oncology
Issue:: Volume 39(2021)Supplement 2
Issue Display:: Volume 39, Issue 2 (2021)
Year:: 2021
Volume:: 39
Issue:: 2
Issue Sort Value:: 2021-0039-0002-0000
Page Start:: n/a
Page End:: n/a
Publication Date:: 2021-06-17
Subjects:: Aggressive T‐cell non‐Hodgkin lymphoma Chemotherapy Combination Therapies
Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.56_2879 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24541.xml